Skip to main content
. 2022 Aug 12;13:939311. doi: 10.3389/fimmu.2022.939311

Figure 3.

Figure 3

Anti-SARS-CoV-2-specific IgG and IgM levels induced by inactivated COVID-19 vaccines. (A, B) Levels of anti-SARS-CoV-2-specific IgG (A) and IgM (B) in serum samples from CoronaVac-vaccinated participants collected on Day 0, Day 28, Day 56, Day 210 and from Covilo-vaccinated participants on Day 56 and Day 210. (C, D) Dynamic changes in anti-SARS-CoV-2-specific IgG (C) and IgM (D) levels between 28 days (Day 56) and 6 months (Day 210) after the second vaccine dose. ns: no significance, P>0.05.